直接口服抗凝药停药后硬膜外血肿一例报告
本病例报告描述一名89岁女性在上腹部手术前停用利伐沙班4天后接受胸段硬膜外镇痛,术后第2天发生T6-T11硬膜外血肿。患者因基础神经功能缺损可能延误了早期发现,因手术候选资格差而选择观察而非手术减压,数月后运动功能部分恢复。作者指出当前停药指南基于药物半衰期而非累积经验,强调对老年及既往神经功能缺损患者需加强监测。
要点
- 停用DOAC后行硬膜外镇痛仍可能发生硬膜外血肿,需保持警惕。
- 老年及既往神经功能缺损患者可能延误血肿的早期识别。
- 此类患者应频繁评估并与基线神经状态对比。
核心结论
- 停用直接口服抗凝药后行椎管内技术仍可能发生硬膜外血肿,当前指南基于药理学半衰期而非累积临床经验。
- 近期停用DOAC联合多个小风险因素累积可能增加患者风险。
- 老年和/或既往神经功能缺损患者早期检测更具挑战性,需要频繁评估并与基线状态对比。
研究设计与样本
- 病例报告:一名89岁女性,因上腹部手术需行胸段硬膜外镇痛。
- 患者既往有脑血管意外致左侧偏瘫和房颤,需利伐沙班抗凝。
- 按当时科室指南术前停用利伐沙班4天,于T8/9放置胸段硬膜外。
主要发现
- 硬膜外置管后5.5小时开始每12小时给予普通肝素,并采用加压装置预防静脉血栓栓塞。
- 术后第2天发现双下肢运动阻滞,影像学显示T6至T11胸段硬膜外血肿。
- 因患者手术候选资格差且预期神经恢复有限,经患者同意后神经外科建议观察而非手术减压。
- 患者随后数月运动功能有适度恢复。
临床怎么用
- 对近期停用DOAC后接受椎管内镇痛的患者,应警惕硬膜外血肿可能。
- 老年及既往神经功能缺损患者需频繁评估神经状态并与基线对比,以避免延误诊断。
- 多学科评估血肿处理策略,综合考虑手术风险与神经恢复预期。
局限性
- 单例病例报告,无法确定因果关系或风险因素。
- 停药指南基于药理学半衰期而非累积临床经验,本案例补充了有限经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this case report, we describe a case of epidural hematoma following epidural analgesia in a patient with recent cessation of a direct oral anticoagulant (DOAC). CASE REPORT: An 89-year-old woman requiring upper abdominal surgery presented with multiple comorbidities, including a prior cerebrovascular accident resulting in a left-sided hemiparesis and atrial fibrillation requiring anticoagulation with rivaroxaban. In accordance with our departmental guidelines at the time of procedure, rivaroxaban was discontinued 4 days preoperatively. A thoracic epidural was placed at T8/9 immediately prior to induction. Venous thromboembolism prophylaxis was provided with compression devices, and every-12-hour unfractionated heparin initiated 5.5 hours after epidural placement. On postoperative day 2, the patient was noted to have a bilateral motor block, and imaging demonstrated a thoracic epidural hematoma extending from T6 to T11. Preexisting neurological deficits may have delayed detection. With patient agreement, neurosurgery recommended observation rather than surgical decompression because the patient was a poor surgical candidate and limited neurologic recovery was expected. The patient had modest motor recovery over the next few months. CONCLUSIONS: Guidelines for cessation of DOACs prior to neuraxial techniques are based on pharmacologic half-lives rather than accumulated experience. This case adds to the experience of neuraxial analgesia complications while following these guidelines. Patient risk may be increased by the combination of recent cessation of a DOAC, as well as the cumulative effect of multiple small risk factors. Continued vigilance and reporting of cases of epidural hematomas will enhance our understanding and ultimately improve patient care. Elderly patients and/or patients with prior neurological deficits may present further challenges for early detection and require frequent assessments with comparison to baseline status.
引用
- Burjorjee JE, Rooney R, Jaeger M, et al. Epidural Hematoma Following Cessation of a Direct Oral Anticoagulant: A Case Report. Reg Anesth Pain Med. 2018. PMID: 29369958. doi:10.1097/AAP.0000000000000738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。